Aspergillosis Clinical Trials

Find Aspergillosis Clinical Trials Near You

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.

• Meets the diagnostic criteria for fungal-sensitized asthma.

Locations
Other Locations
China
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
RECRUITING
Jinan
Contact Information
Primary
Qian Qi, Prof.
qiqianqlh@163.com
+86 13706380314
Time Frame
Start Date: 2025-05-10
Estimated Completion Date: 2029-01-31
Participants
Target number of participants: 140
Treatments
allergic bronchopulmonary aspergillosis
fungal-sensitized asthma
control group
Sponsors
Collaborators: Shanghai Pulmonary Hospital, Shanghai, China, Qilu Hospital of Shandong University, Guizhou Provincial People's Hospital, Fudan University, The First Hospital of Jilin University
Leads: Qianfoshan Hospital

This content was sourced from clinicaltrials.gov